SOX2 and head and neck squamous cell carcinoma: Similarly, in head and neck squamous cell carcinoma (HNSCC), PSMD14 decreased E2F1 ubiquitination and degradation, which improved AKT pathway activation and SOX2 transcription, thereby facilitating HNSCC growth, chemoresistance, and stemness [48].